aluates Reports

$ 0.0

Automative

Global Venous Thromboembolism Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-20U14011

Global Venous Thromboembolism Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Venous Thromboembolism Therapeutics Market Research Report 2025

Code: QYRE-Auto-20U14011

Report

September 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Sanofi

Boehringer Ingelheim

Daiichi Sankyo

Bristol-Myers Squibb(BMS)

Bayer HealthCare

Pfizer Inc

LEO Pharma

Portola Pharmaceuticals

ThromboGenics NV

Ionis Pharmaceuticals

GlycoMimetics

BioInvent International

Johnson & Johnson

Venous Thromboembolism Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Venous Thromboembolism Therapeutics Market

The global market for Venous Thromboembolism Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Therapeutics.

The Venous Thromboembolism Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Venous Thromboembolism Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Venous Thromboembolism Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Venous Thromboembolism Therapeutics Market Report

Report Metric	Details
Report Name	Venous Thromboembolism Therapeutics Market
CAGR	5%
Segment by Type	Factor Xa Inhibitors Direct Thrombin Inhibitors Heparin Vitamin K Antagonists Other
Segment by Application	Hospital Pharmacies Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo, Bristol-Myers Squibb (BMS), Bayer HealthCare, Pfizer, Leo Pharma, Portola Pharmaceuticals, ThromboGenics, Ionis Pharmaceuticals, GlycoMimetics, BioInvent International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Venous Thromboembolism Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Venous Thromboembolism Therapeutics Market report?

Ans: The main players in the Venous Thromboembolism Therapeutics Market are Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo, Bristol-Myers Squibb (BMS), Bayer HealthCare, Pfizer, Leo Pharma, Portola Pharmaceuticals, ThromboGenics, Ionis Pharmaceuticals, GlycoMimetics, BioInvent International

What are the Application segmentation covered in the Venous Thromboembolism Therapeutics Market report?

Ans: The Applications covered in the Venous Thromboembolism Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Other

What are the Type segmentation covered in the Venous Thromboembolism Therapeutics Market report?

Ans: The Types covered in the Venous Thromboembolism Therapeutics Market report are Factor Xa Inhibitors, Direct Thrombin Inhibitors, Heparin, Vitamin K Antagonists, Other

Recommended Reports

Cardiovascular Therapies

Blood Clot Treatments

Therapeutics & Drug Development

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Factor Xa Inhibitors

1.2.3 Direct Thrombin Inhibitors

1.2.4 Heparin

1.2.5 Vitamin K Antagonists

1.2.6 Other

1.3 Market by Application

1.3.1 Global Venous Thromboembolism Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Venous Thromboembolism Therapeutics Market Perspective (2020-2031)

2.2 Global Venous Thromboembolism Therapeutics Growth Trends by Region

2.2.1 Global Venous Thromboembolism Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Venous Thromboembolism Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Venous Thromboembolism Therapeutics Market Dynamics

2.3.1 Venous Thromboembolism Therapeutics Industry Trends

2.3.2 Venous Thromboembolism Therapeutics Market Drivers

2.3.3 Venous Thromboembolism Therapeutics Market Challenges

2.3.4 Venous Thromboembolism Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue

3.1.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Venous Thromboembolism Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Venous Thromboembolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Venous Thromboembolism Therapeutics Revenue

3.4 Global Venous Thromboembolism Therapeutics Market Concentration Ratio

3.4.1 Global Venous Thromboembolism Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapeutics Revenue in 2024

3.5 Global Key Players of Venous Thromboembolism Therapeutics Head office and Area Served

3.6 Global Key Players of Venous Thromboembolism Therapeutics, Product and Application

3.7 Global Key Players of Venous Thromboembolism Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Venous Thromboembolism Therapeutics Breakdown Data by Type

4.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2026-2031)

5 Venous Thromboembolism Therapeutics Breakdown Data by Application

5.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Venous Thromboembolism Therapeutics Market Size (2020-2031)

6.2 North America Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Venous Thromboembolism Therapeutics Market Size by Country (2020-2025)

6.4 North America Venous Thromboembolism Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Venous Thromboembolism Therapeutics Market Size (2020-2031)

7.2 Europe Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Venous Thromboembolism Therapeutics Market Size by Country (2020-2025)

7.4 Europe Venous Thromboembolism Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Venous Thromboembolism Therapeutics Market Size (2020-2031)

9.2 Latin America Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Introduction

11.1.4 Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.1.5 Johnson & Johnson Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Venous Thromboembolism Therapeutics Introduction

11.2.4 Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Introduction

11.3.4 Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Daiichi Sankyo

11.4.1 Daiichi Sankyo Company Details

11.4.2 Daiichi Sankyo Business Overview

11.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Introduction

11.4.4 Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.4.5 Daiichi Sankyo Recent Development

11.5 Bristol-Myers Squibb (BMS)

11.5.1 Bristol-Myers Squibb (BMS) Company Details

11.5.2 Bristol-Myers Squibb (BMS) Business Overview

11.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Introduction

11.5.4 Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.5.5 Bristol-Myers Squibb (BMS) Recent Development

11.6 Bayer HealthCare

11.6.1 Bayer HealthCare Company Details

11.6.2 Bayer HealthCare Business Overview

11.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Introduction

11.6.4 Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.6.5 Bayer HealthCare Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Venous Thromboembolism Therapeutics Introduction

11.7.4 Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Leo Pharma

11.8.1 Leo Pharma Company Details

11.8.2 Leo Pharma Business Overview

11.8.3 Leo Pharma Venous Thromboembolism Therapeutics Introduction

11.8.4 Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.8.5 Leo Pharma Recent Development

11.9 Portola Pharmaceuticals

11.9.1 Portola Pharmaceuticals Company Details

11.9.2 Portola Pharmaceuticals Business Overview

11.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Introduction

11.9.4 Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.9.5 Portola Pharmaceuticals Recent Development

11.10 ThromboGenics

11.10.1 ThromboGenics Company Details

11.10.2 ThromboGenics Business Overview

11.10.3 ThromboGenics Venous Thromboembolism Therapeutics Introduction

11.10.4 ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.10.5 ThromboGenics Recent Development

11.11 Ionis Pharmaceuticals

11.11.1 Ionis Pharmaceuticals Company Details

11.11.2 Ionis Pharmaceuticals Business Overview

11.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Introduction

11.11.4 Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.11.5 Ionis Pharmaceuticals Recent Development

11.12 GlycoMimetics

11.12.1 GlycoMimetics Company Details

11.12.2 GlycoMimetics Business Overview

11.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Introduction

11.12.4 GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.12.5 GlycoMimetics Recent Development

11.13 BioInvent International

11.13.1 BioInvent International Company Details

11.13.2 BioInvent International Business Overview

11.13.3 BioInvent International Venous Thromboembolism Therapeutics Introduction

11.13.4 BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2020-2025)

11.13.5 BioInvent International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Sanofi

Boehringer Ingelheim

Daiichi Sankyo

Bristol-Myers Squibb(BMS)

Bayer HealthCare

Pfizer Inc

LEO Pharma

Portola Pharmaceuticals

ThromboGenics NV

Ionis Pharmaceuticals

GlycoMimetics

BioInvent International

Johnson & Johnson

List of Tables

Table 1. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Factor Xa Inhibitors

Table 3. Key Players of Direct Thrombin Inhibitors

Table 4. Key Players of Heparin

Table 5. Key Players of Vitamin K Antagonists

Table 6. Key Players of Other

Table 7. Global Venous Thromboembolism Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Venous Thromboembolism Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Venous Thromboembolism Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Venous Thromboembolism Therapeutics Market Share by Region (2020-2025)

Table 11. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Venous Thromboembolism Therapeutics Market Share by Region (2026-2031)

Table 13. Venous Thromboembolism Therapeutics Market Trends

Table 14. Venous Thromboembolism Therapeutics Market Drivers

Table 15. Venous Thromboembolism Therapeutics Market Challenges

Table 16. Venous Thromboembolism Therapeutics Market Restraints

Table 17. Global Venous Thromboembolism Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Venous Thromboembolism Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2024)

Table 20. Ranking of Global Top Venous Thromboembolism Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Venous Thromboembolism Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Venous Thromboembolism Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Venous Thromboembolism Therapeutics, Product and Application

Table 24. Global Key Players of Venous Thromboembolism Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Venous Thromboembolism Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Venous Thromboembolism Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Venous Thromboembolism Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Venous Thromboembolism Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Venous Thromboembolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Venous Thromboembolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Venous Thromboembolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Venous Thromboembolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Venous Thromboembolism Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Venous Thromboembolism Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Johnson & Johnson Company Details

Table 50. Johnson & Johnson Business Overview

Table 51. Johnson & Johnson Venous Thromboembolism Therapeutics Product

Table 52. Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Johnson & Johnson Recent Development

Table 54. Sanofi Company Details

Table 55. Sanofi Business Overview

Table 56. Sanofi Venous Thromboembolism Therapeutics Product

Table 57. Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Sanofi Recent Development

Table 59. Boehringer Ingelheim Company Details

Table 60. Boehringer Ingelheim Business Overview

Table 61. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product

Table 62. Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 63. Boehringer Ingelheim Recent Development

Table 64. Daiichi Sankyo Company Details

Table 65. Daiichi Sankyo Business Overview

Table 66. Daiichi Sankyo Venous Thromboembolism Therapeutics Product

Table 67. Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Daiichi Sankyo Recent Development

Table 69. Bristol-Myers Squibb (BMS) Company Details

Table 70. Bristol-Myers Squibb (BMS) Business Overview

Table 71. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product

Table 72. Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Bristol-Myers Squibb (BMS) Recent Development

Table 74. Bayer HealthCare Company Details

Table 75. Bayer HealthCare Business Overview

Table 76. Bayer HealthCare Venous Thromboembolism Therapeutics Product

Table 77. Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 78. Bayer HealthCare Recent Development

Table 79. Pfizer Company Details

Table 80. Pfizer Business Overview

Table 81. Pfizer Venous Thromboembolism Therapeutics Product

Table 82. Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Pfizer Recent Development

Table 84. Leo Pharma Company Details

Table 85. Leo Pharma Business Overview

Table 86. Leo Pharma Venous Thromboembolism Therapeutics Product

Table 87. Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Leo Pharma Recent Development

Table 89. Portola Pharmaceuticals Company Details

Table 90. Portola Pharmaceuticals Business Overview

Table 91. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product

Table 92. Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Portola Pharmaceuticals Recent Development

Table 94. ThromboGenics Company Details

Table 95. ThromboGenics Business Overview

Table 96. ThromboGenics Venous Thromboembolism Therapeutics Product

Table 97. ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 98. ThromboGenics Recent Development

Table 99. Ionis Pharmaceuticals Company Details

Table 100. Ionis Pharmaceuticals Business Overview

Table 101. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product

Table 102. Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 103. Ionis Pharmaceuticals Recent Development

Table 104. GlycoMimetics Company Details

Table 105. GlycoMimetics Business Overview

Table 106. GlycoMimetics Venous Thromboembolism Therapeutics Product

Table 107. GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 108. GlycoMimetics Recent Development

Table 109. BioInvent International Company Details

Table 110. BioInvent International Business Overview

Table 111. BioInvent International Venous Thromboembolism Therapeutics Product

Table 112. BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2020-2025) & (US$ Million)

Table 113. BioInvent International Recent Development

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

Table 117. Authors List of This Report

List of Figures

Figure 1. Venous Thromboembolism Therapeutics Picture

Figure 2. Global Venous Thromboembolism Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Venous Thromboembolism Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Factor Xa Inhibitors Features

Figure 5. Direct Thrombin Inhibitors Features

Figure 6. Heparin Features

Figure 7. Vitamin K Antagonists Features

Figure 8. Other Features

Figure 9. Global Venous Thromboembolism Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Venous Thromboembolism Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Other Case Studies

Figure 14. Venous Thromboembolism Therapeutics Report Years Considered

Figure 15. Global Venous Thromboembolism Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Venous Thromboembolism Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Venous Thromboembolism Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Venous Thromboembolism Therapeutics Market Share by Players in 2024

Figure 19. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2024

Figure 21. North America Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Venous Thromboembolism Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Venous Thromboembolism Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Region (2020-2031)

Figure 35. China Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Venous Thromboembolism Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Venous Thromboembolism Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Johnson & Johnson Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 51. Sanofi Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 53. Daiichi Sankyo Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 54. Bristol-Myers Squibb (BMS) Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 55. Bayer HealthCare Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 56. Pfizer Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 57. Leo Pharma Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 58. Portola Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 59. ThromboGenics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 60. Ionis Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 61. GlycoMimetics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 62. BioInvent International Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Deep Vein Thrombosis DVT Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Venous Diseases Treatment Market Research Report 2025

Global Thrombolytic Treatment Market Research Report 2024

Global Anticoagulant Medicine Market Research Report 2025

Global Arterial Thrombosis Drug Market Research Report 2024

Cerebral Vein Thrombosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Heparin Drugs Market Research Report 2024

Varicose Veins Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Venous Leg Ulcers Treatment Market Research Report 2024

Therapeutic Varicose Vein Socks Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radioembolization Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti VEGF Medicine Market Research Report 2024

Anti VEGF Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Varicose Compression Stockings Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Venous Occlusions Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

VEGF VEGFR Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025

Cardiovascular Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stroke Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions